Are Mood Swings a Side Effect of Ozempic?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 receptor agonists work primarily in the gut and pancreas, yet some patients report shifts in mood or emotional stability during treatment. While clinical trials show mood changes occur in less than 2% of users, understanding the connection between weight loss medication and brain chemistry helps you recognize what's normal and when to contact your doctor.

How GLP-1 Medications Affect Brain Chemistry and Mood

GLP-1 receptors exist not only in the digestive system but also in regions of the brain that regulate appetite, reward, and emotional processing. When semaglutide activates these receptors, it can influence neurotransmitter levels, particularly serotonin and dopamine pathways. This dual action—weight loss combined with subtle shifts in brain signaling—explains why a small subset of patients experience mood-related changes.

The relationship between rapid weight loss and emotional state is also bidirectional. Dropping pounds quickly can trigger positive mood shifts from improved self-esteem and energy levels, yet it may also unmask underlying anxiety or depression that was previously masked by comfort eating patterns. Most users report stable or improved mood as they lose weight and health markers improve.

Clinical Evidence: Are Mood Swings a Common Side Effect?

Major clinical trials for semaglutide, including the SUSTAIN series and real-world monitoring of Ozempic users, show that mood disorders occur in fewer than 2% of patients and are typically mild or transient. The FDA's adverse event database does not list mood swings as a primary or frequent side effect, though individual case reports exist. Depression and anxiety occurred at similar rates in placebo groups, suggesting many mood changes are unrelated to the medication itself.

Emotional changes that do occur often resolve within weeks as your body adjusts to the medication. However, if you have a personal or family history of depression, bipolar disorder, or anxiety, your doctor should monitor your mood more closely during treatment initiation and dose escalation.

How Your Genetics Relate to GLP-1 Pathways

The PlexusDx Precision Peptide Genetic Test analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

By mapping your genetic peptide profile before or during your first month of treatment, PlexusDx can identify whether you're genetically predisposed to mood sensitivity with GLP-1 therapy. This personalized data guides your doctor to choose the right compound (semaglutide, tirzepatide, or a dual GLP-Squared formula), starting dose, and escalation schedule to minimize emotional disruption while maximizing weight loss results.

When to Contact Your Doctor About Mood Changes

Reach out to your PlexusDx doctor immediately if you experience persistent sadness, hopelessness, thoughts of self-harm, sudden anger outbursts, or a significant loss of interest in activities you normally enjoy. Likewise, if mood changes coincide with starting or increasing your semaglutide dose and don't improve within two weeks, your doctor may adjust your protocol or add emotional support resources.

Many mood-related symptoms during GLP-1 therapy are temporary and manageable. Your doctor can differentiate between normal emotional adjustment to rapid weight loss, medication-related mood shifts, and signs of clinical depression requiring additional intervention. Open communication about your emotional state is just as important as tracking your weight and appetite.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can semaglutide actually cause mood swings?

Mood swings are uncommon with semaglutide, occurring in fewer than 2% of users in clinical trials. Most mood changes during GLP-1 therapy are mild, temporary, and often related to rapid weight loss and lifestyle adjustment rather than the medication itself. If you do experience mood shifts, they typically resolve within weeks as your body adapts.

What does the research say about GLP-1 drugs and depression?

Clinical trials show depression and anxiety rates in GLP-1 users are similar to placebo groups, suggesting these emotions are not primarily medication-induced. However, GLP-1 receptors in the brain do modulate neurotransmitter pathways, so individual sensitivity varies. Patients with untreated mental health conditions should inform their doctor before starting therapy.

How much does semaglutide cost at PlexusDx, and can I start with genetic testing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Should I stop taking semaglutide if I notice mood changes?

Do not stop semaglutide without consulting your doctor, as abrupt discontinuation can cause rebound appetite and rapid weight regain. Instead, contact your PlexusDx provider immediately to discuss your mood changes. Your doctor may adjust your dose, switch to a different GLP-1 compound, or recommend additional mental health support to keep you on a safe, sustainable path.

How does the Precision Peptide Genetic Test help with mood and side effects?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Side Effects
• Does My Dna Determine If I M Prone To Hormonerelated Mood Swings
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.